United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Apr 21, 2026 · Filed Apr 22, 2026

On Apr 21, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$570.42 for US$5.42M under a trading plan, leaving 40,513 shares. Filed Apr 22, 2026 (Form 4).

Sold
9,500 shares
Price
US$570.42 average (US$564.35 to US$575.72)
Value
US$5.42M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 21, 2026Common StockOption exercise7,500US$146.0348,013Direct
Apr 21, 2026Common StockOption exercise2,000US$146.0350,013Direct
Apr 21, 2026Common StockSale159US$564.3549,854Direct
Apr 21, 2026Common StockSale539US$565.5149,315Direct
Apr 21, 2026Common StockSale1,347US$566.5647,968Direct
Apr 21, 2026Common StockSale1,206US$567.5446,762Direct
Apr 21, 2026Common StockSale269US$568.2146,493Direct
Apr 21, 2026Common StockSale680US$569.7145,813Direct
Apr 21, 2026Common StockSale945US$570.6544,868Direct
Apr 21, 2026Common StockSale1,215US$571.6443,653Direct
Apr 21, 2026Common StockSale410US$572.4843,243Direct
Apr 21, 2026Common StockSale1,366US$573.4841,877Direct
Apr 21, 2026Common StockSale701US$574.9141,176Direct
Apr 21, 2026Common StockSale663US$575.7240,513Direct

Source

View original at SEC

Related